Extended orgasm with Tramadol

[Mr. Bob]

SWIM have been working with Tantra meditation for quite some time. Able to have long orgasm without ejaculating through practice.

Tramadol makes SWIM very horny. Orgasm becomes hard to have as dose increases. Orgasm on moderate dose of Tramadol was very much drawn out and intense. Definately inhances pleasure. Came slow and intense like a faucet instead of usual quick spurts.

SWIM's lover (female) says her orgasm was slower, drawn out as well, and a little more intense than usual.

[tucker dread]

What dosage did swiy take?. Also was it Tramadol SR (sustained release or Tramadol (immediate release) ?

[[tanarilla.]]

How strange, Tramadol also makes my bunny extremely horny, and feels an almost orgasmic body high for 8 hours with higher dosages.

[john61]

Swim also uses tramadol from time to time at 150-200mg to help slow down ejaculation and also finds it great all round for sex.

[Bajeda]

Emad A. Salem, Steven K. Wilson, Nabil K. Bissada, et al. (2008). Tramadol HCL has Promise in On-Demand Use to Treat Premature Ejaculation. Journal of Sexual Medicine, 5(1): 188-193.

Introduction: Premature ejaculation (PE) is a worldwide problem without an approved treatment. Selective serotonin reuptake inhibitors (SSRIs) are widely used "off label" as pharmacotherapeutic agents in the treatment of PE.

Aim: This study investigates Tramadol efficacy for on-demand treatment of PE.

Main Outcomes Measures: Intravaginal ejaculation latency time (IELT) was used as an objective tool to assess the efficacy of the investigated treatments.

Materials and Methods: Single-blind, placebo-controlled, crossover, stopwatch monitored two-period study was conducted, on 60 patients with lifelong PE. PE was defined as IELT of <2 minutes in 80% of intercourse episodes. A total of 25 mg of Tramadol hydrochloride was given to one group (30) prior to intercourse and placebo was supplied for the other group (30) for 8 weeks. Drugs were taken 1–2 hours before sexual activity and sexual intercourse was required at least once per week. After the initial treatment period, the two groups took the alternate medication for another 2 months. The two 8-week treatment periods were separated by 1 week washout period. IELT was timed by a stopwatch at each intercourse and was reported by patients or partners.

Results: The baseline (mean ± SD) IELT for patients before treatment was 1.17 ± 0.39 minutes. At the end of the treatment period utilizing the active drug, the mean IELT was increased significantly in patients on Tramadol treatment to 7.37 ± 2.53 minutes. The same patients on placebo medication had mean IELT of only 2.01 ± 0.71 minutes. Patients uniformly reported satisfaction with their resulting control over ejaculation.


Conclusions: Tramadol, a drug with a proven safety record as an anti-inflammatory agent, shows promise as a drug for treating rapid ejaculation.








Safarinejad MR, Hosseini SY. Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol. 2006 Feb;26(1):27-31.

PURPOSE: To evaluate the efficacy and safety of a new serotonergic centrally acting drug tramadol in delaying ejaculation in patients with premature ejaculation.



MATERIALS AND METHODS: Sixty-four potent men with premature ejaculation were randomly assigned to receive 50 mg tramadol (group 1, n = 32) or placebo (group 2, n = 32) approximately 2 hours before planned sexual activity, for 8 weeks. Pretreatment evaluation included history and physical examination, intravaginal ejaculatory latency time, International Index of Erectile Function, and Meares-Stamey test. The efficacy of 2 treatments was assessed using responses to International Index of Erectile Function, intravaginal ejaculatory latency time evaluation, and several general assessment questions.



RESULTS: Fifty-seven (89%) completed the whole treatment schedule. The mean intravaginal ejaculatory latency time after tramadol and placebo increased from 19 and 21 seconds to approximately 243 and 34 seconds, respectively (P < 0.001). The mean weekly intercourse episodes increased from pretreatment values of 1.07 and 1.1 to 2.3 and 1.3, for tramadol and placebo, respectively (P < 0.05). Baseline mean intercourse satisfaction domain values of International Index of Erectile Function 10 and 11 reached to 14 and 10 at 8-week treatment in groups 1 and 2, respectively (P < 0.05). There was no withdrawal caused by adverse effects with tramadol or placebo, but more adverse events were associated with tramadol treatment (P < 0.05).


CONCLUSIONS: Tramadol seems to provide significantly better results in terms of intravaginal ejaculatory latency time and intercourse satisfaction versus placebo. Further studies are required to draw final conclusions on the efficacy of this drug in premature ejaculation.